Literature DB >> 19816656

Utilization and outcome of thrombolytic therapy for acute stroke in Pakistan.

Mohammad Wasay1, Hazim Barohi, Abdul Malik, Adnan Yousuf, Safia Awan, Ayeesha K Kamal.   

Abstract

Our objective was to identify the outcome of patients treated with tissue plasminogen activator (r-tPa) in Pakistan and compare these data to available regional and international data. The charts of all patients treated with r-tPa for acute stroke at two centers in Pakistan (Aga Khan University, Karachi and Liaquat National hospital, Karachi) were retrospectively reviewed. We identified 21 patients. The utilization of tPa at Aga Khan Hospital was 18/1,185 patients (1.5%) from 2005 to 2007 while at Liaquat National Hospital was 3/575 patients (0.52%) over 1 year (2007). Mean time interval between stroke onset and start of r-tPa infusion was 169 min. Three patients (14%) developed fatal hemorrhage and two (10%) developed non-fatal hemorrhage. Four patients (19%) died. We identified protocol violations in seven patients (33%). In conclusion, the utilization of thrombolytic therapy is low and complication rate is high. Interventions for training physicians are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816656     DOI: 10.1007/s10072-009-0159-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

Review 1.  The global stroke initiative.

Authors:  Ruth Bonita; Shanthi Mendis; Thomas Truelsen; Julien Bogousslavsky; James Toole; Frank Yatsu
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

2.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

3.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

4.  Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation.

Authors:  Nijasri C Suwanwela; Kammant Phanthumchinda; Yuttachai Likitjaroen
Journal:  Clin Neurol Neurosurg       Date:  2005-11-09       Impact factor: 1.876

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 6.  Stroke and thrombolysis in developing countries.

Authors:  Jeyaraj Durai Pandian; Vasantha Padma; Pamidimukkala Vijaya; P N Sylaja; Jagaralpudi M K Murthy
Journal:  Int J Stroke       Date:  2007-02       Impact factor: 5.266

7.  Early ischemic stroke presentation in Pakistan.

Authors:  Ayeesha Kamran Kamal; Bhojo Asumal Khealani; Sajjad Ahmed Ansari; Maria Afridi; Nadir Ali Syed
Journal:  Can J Neurol Sci       Date:  2009-03       Impact factor: 2.104

8.  Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.

Authors:  Glenn D Graham
Journal:  Stroke       Date:  2003-11-06       Impact factor: 7.914

9.  Feasibility of acute thrombolytic therapy for stroke.

Authors:  K Nandigam; S K Narayan; S Elangovan; T K Dutta; K R Sethuraman; A K Das
Journal:  Neurol India       Date:  2003-12       Impact factor: 2.117

10.  Frequency and outcome of carotid atheromatous disease in patients with stroke in Pakistan.

Authors:  Mohammad Wasay; Muhammad Azeemuddin; Imrana Masroor; Zafar Sajjad; Rasheed Ahmed; Bhojo A Khealani; Muhammad Ashar Malik; Maria Babar Afridi; Ayeesha Kamal
Journal:  Stroke       Date:  2009-01-22       Impact factor: 7.914

View more
  11 in total

Review 1.  The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models.

Authors:  Maarten M H Lahr; Gert-Jan Luijckx; Patrick C A J Vroomen; Durk-Jouke van der Zee; Erik Buskens
Journal:  J Neurol       Date:  2012-08-23       Impact factor: 4.849

2.  Barriers of thrombolysis therapy in developing countries.

Authors:  Kavian Ghandehari
Journal:  Stroke Res Treat       Date:  2011-03-17

3.  Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cerebral infarction following urokinase thrombolysis in rats.

Authors:  Yuqiang Song; Hongli Zou; Guofeng Wang; Hongxia Yang; Zhaohong Xie; Jianzhong Bi
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

4.  Acute stroke care and thrombolytic therapy use in a tertiary care center in Lebanon.

Authors:  Mazen J El Sayed; Tharwat El Zahran; Hani Tamim
Journal:  Emerg Med Int       Date:  2014-07-16       Impact factor: 1.112

5.  Hurdles in stroke thrombolysis: Experience from 100 consecutive ischemic stroke patients.

Authors:  Sagar Badachi; Thomas Mathew; Arvind Prabhu; Raghunandan Nadig; Gosala R K Sarma
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

6.  Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study.

Authors:  Elyar Sadeghi-Hokmabadi; Mehdi Farhoudi; Aliakbar Taheraghdam; Mazyar Hashemilar; Daryous Savadi-Osguei; Reza Rikhtegar; Kaveh Mehrvar; Ehsan Sharifipour; Parisa Youhanaee; Reshad Mirnour
Journal:  Int J Gen Med       Date:  2016-10-25

7.  Performance measures for in-hospital care of acute ischemic stroke in public hospitals in Chile.

Authors:  Lorena Hoffmeister; Pablo M Lavados; Merce Comas; Carolina Vidal; Rodrigo Cabello; Xavier Castells
Journal:  BMC Neurol       Date:  2013-03-06       Impact factor: 2.474

8.  Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation.

Authors:  Hormoz Ayromlou; Hassan Soleimanpour; Mehdi Farhoudi; Aliakbar Taheraghdam; Elyar Sadeghi Hokmabadi; Rouzbeh Rajaei Ghafouri; Mehdi Najafi Nashali; Ehsan Sharifipour; Somayeh Mostafaei; Davar Altafi
Journal:  Iran Red Crescent Med J       Date:  2014-05-05       Impact factor: 0.611

9.  Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.

Authors:  Xia Wang; Shoujiang You; Shoichiro Sato; Jie Yang; Cheryl Carcel; Danni Zheng; Sohei Yoshimura; Craig S Anderson; Else Charlotte Sandset; Thompson Robinson; John Chalmers; Vijay K Sharma
Journal:  Stroke Vasc Neurol       Date:  2018-01-13

Review 10.  Acute care for the three leading causes of mortality in lower-middle-income countries: A systematic review.

Authors:  Cassidy M Dahn; Olindi Wijesekera; Grace E Garcia; Konrad Karasek; Gabrielle A Jacquet
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.